Theravance Biopharma
TBPH
#6135
Rank
$0.43 B
Marketcap
Cayman Islands
Country
$8.99
Share price
-1.43%
Change (1 day)
-18.35%
Change (1 year)
Categories
Theravance Biopharma (TBPH) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.16 B
According to Theravance Biopharma 's latest financial reports the company's total liabilities are $0.16 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Theravance Biopharma - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.16 B | 2.06% |
| 2022-12-31 | $0.16 B | -76.79% |
| 2021-12-31 | $0.71 B | -7.69% |
| 2020-12-31 | $0.77 B | 22.15% |
| 2019-12-31 | $0.63 B | 3.41% |
| 2018-12-31 | $0.61 B | 87.55% |
| 2017-12-31 | $0.32 B | 12.87% |
| 2016-12-31 | $0.28 B | 406.6% |
| 2015-12-31 | $57.05 M | 18.9% |
| 2014-12-31 | $47.98 M | 13.67% |
| 2013-12-31 | $42.21 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Corcept Therapeutics
CORT | $0.11 B | -32.07% | 🇺🇸 USA |
 Collegium Pharmaceutical
COLL | $0.94 B | 460.86% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $82.23 M | -51.34% | 🇺🇸 USA |
 Catalent CTLT | $6.30 B | 3,628.31% | 🇺🇸 USA |